{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:08:24Z","timestamp":1763507304786,"version":"3.45.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11985-1","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:58:53Z","timestamp":1763463533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of voriconazole therapy for pulmonary cryptococcosis in fluconazole treatment failure: a multicenter real-world study"],"prefix":"10.1186","volume":"25","author":[{"given":"Dian","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexiang","family":"Shui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghua","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fugui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"1","key":"11985_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","volume":"30","author":"EK Maziarz","year":"2016","unstructured":"Maziarz EK, Perfect JR, Cryptococcosis. Infect Dis Clin North Am. 2016;30(1):179\u2013206.","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"11985_CR2","first-page":"227","volume":"62","author":"C Emmons","year":"1955","unstructured":"Emmons C. Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columba livia). Am J Hyg. 1955;62(3):227\u201332.","journal-title":"Am J Hyg"},{"key":"11985_CR3","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1128\/jcm.28.7.1642-1644.1990","volume":"28","author":"D Ellis","year":"1990","unstructured":"Ellis D, Pfeiffer T. Natural habitat of Cryptococcus neoformans var Gattii. J Clin Microbiol. 1990;28:1642\u20134.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"11985_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrmicro2522","volume":"9","author":"JW Kronstad","year":"2011","unstructured":"Kronstad JW, Attarian R, Cadieux B, et al. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol. 2011;9(3):193\u2013203.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"11985_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/mmy\/myy086","volume":"57","author":"F Setianingrum","year":"2019","unstructured":"Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: A review of pathobiology and clinical aspects. Med Mycol. 2019;57(2):133\u201350.","journal-title":"Med Mycol"},{"issue":"1","key":"11985_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/22221751.2021.1894902","volume":"10","author":"Z Li","year":"2021","unstructured":"Li Z, Li Y, Chen Y. Trends of pulmonary fungal infections from 2013 to 2019: an AI-based real-world observational study in Guangzhou, China. Emerg Microbes Infect. 2021;10(1):450\u201360.","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"11985_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cid\/ciz193","volume":"70","author":"KA Marr","year":"2020","unstructured":"Marr KA, Sun Y, Spec A. Cryptococcus infection network cohort study working Group. A Multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency Virus-negative people in the united States. Clin Infect Dis. 2020;70(2):252\u201361.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"11985_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00408-011-9362-8","volume":"190","author":"F Ye","year":"2012","unstructured":"Ye F, Xie JX, Zeng QS. Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis. Lung. 2012;190(3):339\u201346.","journal-title":"Lung"},{"issue":"5","key":"11985_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1086\/322597","volume":"33","author":"PG Pappas","year":"2001","unstructured":"Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective Azole therapy. Clin Infect Dis. 2001;33(5):690\u20139.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"11985_CR10","first-page":"86","volume":"34","author":"YN Liu","year":"2011","unstructured":"Liu YN, She DY, Sun TY, et al. [A multicentre retrospective study of pulmonary mycosis clinically proven from 1998 to 2007]. Zhonghua Jie He He Hu Xi Za Zhi. 2011;34(2):86\u201390. Chinese.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"11985_CR11","doi-asserted-by":"crossref","unstructured":"Chang CC, Harrison TS, Bicanic TA et al. Global guideline for the diagnosis and management of Cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis. 2024;24(8):e495-e512. Epub 2024 Feb 9.","DOI":"10.1016\/S1473-3099(23)00731-4"},{"issue":"1","key":"11985_CR12","doi-asserted-by":"publisher","first-page":"ofaa004","DOI":"10.1093\/ofid\/ofaa004","volume":"7","author":"S Wei","year":"2020","unstructured":"Wei S, Su X, Pan YH, et al. Postoperative antifungal treatment of pulmonary cryptococcosis in Non-HIV-Infected and Non-Transplant-Recipient patients: A report of 110 cases and literature review. Open Forum Infect Dis. 2020;7(1):ofaa004.","journal-title":"Open Forum Infect Dis"},{"key":"11985_CR13","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.2147\/IDR.S491615","volume":"17","author":"Y Yang","year":"2024","unstructured":"Yang Y, Shang J, Xu S, et al. Dose optimization of fluconazole after initial treatment failure in pulmonary cryptococcosis in an obese patient with type 2 diabetes and cirrhosis: A case report. Infect Drug Resist. 2024;17:4993\u20135000.","journal-title":"Infect Drug Resist"},{"issue":"34","key":"11985_CR14","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.3346\/jkms.2018.33.e213","volume":"33","author":"HS Kim","year":"2018","unstructured":"Kim HS, Lee S, Kim JH. Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records. J Korean Med Sci. 2018;33(34):e213.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"11985_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12931-025-03283-w","volume":"26","author":"M Chen","year":"2025","unstructured":"Chen M, Chen S, Wang M, et al. A multicenter prospective clinical cohort study of pulmonary cryptococcosis in adult non-HIV-infected patients in a southeastern Province of China. Respir Res. 2025;26(1):216.","journal-title":"Respir Res"},{"key":"11985_CR16","doi-asserted-by":"crossref","unstructured":"Thompson GR 3rd, Rendon A, Ribeiro Dos Santos R, et al. Isavuconazole treatment of cryptococcosis and dimorphic mycoses. Clin Infect Dis. 2016;63(3):356\u201362.","DOI":"10.1093\/cid\/ciw305"},{"key":"11985_CR17","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Versio5.0. (Accessed 17 January 2019). http:\/\/www.ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf."},{"key":"11985_CR18","doi-asserted-by":"publisher","first-page":"e002002025","DOI":"10.1590\/0037-8682-0328-2024","volume":"58","author":"IMB Moreira","year":"2025","unstructured":"Moreira IMB, Sousa NSO, Almeida JDR, et al. Fluconazole resistance and heteroresistance in Cryptococcus spp.: mechanisms and implications. Rev Soc Bras Med Trop. 2025;58:e002002025.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"7","key":"11985_CR19","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1128\/IAI.68.7.4225-4237.2000","volume":"68","author":"M Feldmesser","year":"2000","unstructured":"Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun. 2000;68(7):4225\u201337.","journal-title":"Infect Immun"},{"issue":"8","key":"11985_CR20","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1128\/AAC.43.8.1856","volume":"43","author":"P Mondon","year":"1999","unstructured":"Mondon P, Petter R, Amalfitano G, Luzzati R, Concia E, Polacheck I, Kwon-Chung KJ. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob Agents Chemother. 1999;43(8):1856\u201361.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"11985_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1172\/JCI124516","volume":"129","author":"NR Stone","year":"2019","unstructured":"Stone NR, et al. Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis. J Clin Invest. 2019;129(3):999\u20131014.","journal-title":"J Clin Invest"},{"issue":"4","key":"11985_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1534\/g3.116.037499","volume":"G3","author":"J Rhodes","year":"2017","unstructured":"Rhodes J, et al. A population genomics approach to assessing the genetic basis of Within-Host microevolution underlying recurrent Cryptococcal meningitis infection. (Bethesda). 2017;G3(4):1165\u201376.","journal-title":"(Bethesda)"},{"key":"11985_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.mib.2019.11.001","volume":"52","author":"H Zafar","year":"2019","unstructured":"Zafar H, Altamirano S, Ballou ER, Nielsen K. A titanic drug resistance threat in Cryptococcus neoformans. Curr Opin Microbiol. 2019;52:158\u201364. Epub 2019 Nov 22.","journal-title":"Curr Opin Microbiol"},{"issue":"7","key":"11985_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","volume":"19","author":"KR Iyer","year":"2021","unstructured":"Iyer KR, Revie NM, Fu C, Robbins N, Cowen LE. Treatment strategies for Cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol. 2021;19(7):454\u201366.","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"11985_CR25","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3390\/pharmaceutics15071781","volume":"15","author":"KJ Staudt","year":"2023","unstructured":"Staudt KJ, Dias BB, Alves IA, et al. Modeling and simulation as a tool to assess voriconazole exposure in the central nervous system. Pharmaceutics. 2023;15(7):1781.","journal-title":"Pharmaceutics"},{"issue":"11","key":"11985_CR26","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/ctr.12834","volume":"30","author":"MT Levine","year":"2016","unstructured":"Levine MT, Chandrasekar PH. Adverse effects of voriconazole: over a decade of use. Clin Transpl. 2016;30(11):1377\u201386.","journal-title":"Clin Transpl"},{"issue":"12","key":"11985_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.clinthera.2022.10.005","volume":"44","author":"Y Takesue","year":"2022","unstructured":"Takesue Y, Hanai Y, Oda K, et al. Japanese antimicrobial therapeutic drug monitoring guideline Committee. Clinical practice guideline for the therapeutic drug monitoring of voriconazole in Non-Asian and Asian adult patients: consensus review by the Japanese society of chemotherapy and the Japanese society of therapeutic drug monitoring. Clin Ther. 2022;44(12):1604\u201323.","journal-title":"Clin Ther"},{"issue":"8","key":"11985_CR28","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40265-019-01127-8","volume":"79","author":"LL Benitez","year":"2019","unstructured":"Benitez LL, Carver PL. Adverse effects associated with Long-Term administration of Azole antifungal agents. Drugs. 2019;79(8):833\u201353.","journal-title":"Drugs"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11985-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11985-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11985-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:04:33Z","timestamp":1763507073000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11985-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11985"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11985-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by Human Research Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (2024-1260). Informed consent was waived by the Ethics Committee due to the retrospective nature of the study and the use of anonymized data. The study complied with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1609"}}